Main Article Content
Mutia Devi
Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia;
Muhammad Izazi Hari Purwoko
Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia;
Suroso Adi Nugroho
Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia;
Yulia Farida Yahya
Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia;
Indah Astri Aryani
Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia;
Kiki Septiafni
Department of Dermatology and Venereology, Medical Faculty of Universitas Sriwijaya/ Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia;
Keywords
Mucocutaneous manifestations, human immunodeficiency virus, acquired immunodeficiency syndrome
Abstract
Mucocutaneous manifestations are the first recognized human immunodeficiency virus (HIV) infections. More than 90% of HIV-infected patients develop at least one or more types of typical or atypical skin lesions during the disease. Mucocutaneous manifestation can also indicate the progression of HIV infection and cluster of differentiation 4 (CD4) cell count as an indicator of the development of acquired immunodeficiency syndrome (AIDS). It is important to know mucocutaneous manifestations and their correlation with the patient’s immune status to provide appropriate treatment to improve the patient’s quality of life.
Abstract 537 |
pdf Downloads 1047